Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Dr. Reddy's Laboratories Ltd (RDY) had Tangible Shareholders Equity of $2.80B for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$1.01B |
|
$165.28M |
|
$458.98M |
|
$553.61M |
|
$811.19M |
|
$201.40M |
|
$9.63M |
|
$211.03M |
|
$211.03M |
|
$164.08M |
|
$164.08M |
|
$164.08M |
|
$164.08M |
|
$201.40M |
|
$256.40M |
|
832.63M |
|
833.05M |
|
$0.20 |
|
$0.20 |
|
| Balance Sheet Financials | |
$3.15B |
|
$1.26B |
|
$2.96B |
|
$6.11B |
|
$1.70B |
|
$131.00M |
|
$327.00M |
|
$2.03B |
|
$4.08B |
|
|
Tangible Shareholders Equity |
$2.80B |
$4.08B |
|
834.61M |
|
| Cash Flow Statement Financials | |
$340.00M |
|
$-324.00M |
|
$-75.00M |
|
$164.00M |
|
$112.00M |
|
$-52.00M |
|
$2.00M |
|
$-75.00M |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.85 |
|
-- |
|
-- |
|
0.03 |
|
0.16 |
|
54.67% |
|
19.89% |
|
19.89% |
|
-- |
|
20.84% |
|
16.32% |
|
$206.00M |
|
-- |
|
-- |
|
-- |
|
0.17 |
|
0.54 |
|
0.92 |
|
97.86 |
|
4.02% |
|
5.86% |
|
2.69% |
|
3.90% |
|
$4.89 |
|
$0.25 |
|
$0.41 |
|